Edition:
United States

Acasti Pharma Inc (ACST.O)

ACST.O on Consolidated Issue listed on NASDAQ Capital Market

1.50USD
28 Jul 2016
Change (% chg)

-- (--)
Prev Close
$1.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
18,661
52-wk High
$4.20
52-wk Low
$1.20

Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - Acasti Pharma Inc (APO-V) 28 Jul 2016 Thomson Reuters Stock Report 11 25.00
Acasti Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 22 Jul 2016 Reuters Investment Profile 12 20.00
ACASTI PHARMA INC (ACST=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS 22 Jul 2016 Pechala's Reports 2 25.00
Wright Investors Service Comprehensive Report for Acasti Pharma Inc 4 Jul 2016 Wright Reports 58 75.00
Acasti Pharma Inc. (APO) - Financial Analysis Review 16 May 2016 GlobalData 40 300.00
Thomson Reuters Stock Report - Acasti Pharma Inc (APO-V) 10 May 2016 Thomson Reuters Stock Report 11 25.00
 
Name Age Since Current Position

Roderick Carter

2016 Executive Chairman of the Board

Jan D'Alvise

2016 President, Chief Executive Officer

Mario Paradis

2015 Chief Financial Officer

Pierre Lemieux

2010 Chief Operating Officer

Laurent Harvey

Vice President- Clinical and Non-Clinical Affairs